Unum Therapeutics Inc (NASDAQ:UMRX)

0.6866
Delayed Data
As of Dec 06
 +0.0159 / +2.37%
Today’s Change
0.58
Today|||52-Week Range
6.74
-84.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues3.0M6.4M8.4M9.7M
 
 
 
 
 
Depreciation And Amortization179.0K830.0K1.2M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses9.4M24.6M33.3M44.4M
 
 
 
 
 
Research And Development6.9M22.0M29.8M38.3M
 
 
 
 
 
Total Operating Expenses9.6M25.4M34.5M45.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.6M-19.1M-26.2M-36.0M
 
 
 
 
 
Other Expenses0.00681.0K274.0K320.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.6M-18.1M-25.5M-34.5M
 
 
 
 
 
Net Income-6.6M-18.2M-25.6M-34.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.0M30.5M30.5M24.9M
 
 
 
 
 
Shares To Calculate EPS Diluted16.0M30.5M30.5M24.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41-$0.60-$0.84-$1.39
 
 
 
 
 
EPS Diluted-$0.41-$0.60-$0.84-$1.39